Larimar Therapeutics Inc.
3.44
0.15 (4.56%)
At close: Jan 15, 2025, 9:35 AM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11
Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue 311.00K 272.00K 326.00K 155.00K 78.00K 261.00K 188.00K 212.00K 70.00K n/a 12.00K 11.00K 4.00K
Gross Profit -311.00K -272.00K -326.00K -155.00K -78.00K -261.00K -188.00K -212.00K -70.00K n/a -12.00K -11.00K -4.00K
Operating Income -41.76M -36.53M -50.47M -42.80M -23.21M -62.72M -53.88M -57.12M -73.81M -35.53M -13.78M -13.79M -13.15M
Interest Income n/a n/a n/a n/a n/a n/a 996.00K 894.00K 438.00K 28.00K n/a n/a n/a
Pretax Income -36.95M -35.35M -50.64M -42.48M -23.13M -62.97M -52.93M -58.18M -74.29M -36.57M -14.03M -13.88M -13.16M
Net Income -36.95M -34.18M -50.31M -42.33M -23.13M -61.37M -52.03M -57.88M -74.29M -36.57M -14.03M -13.88M -13.16M
Selling & General & Admin 14.09M 12.28M 12.07M 11.40M 2.42M 12.93M 11.95M 17.14M 19.13M 8.14M 4.21M 2.24M 1.75M
Research & Development 27.36M 24.25M 38.40M 31.41M 20.79M 49.53M 41.74M 39.77M 54.62M 27.39M 9.56M 11.54M 11.40M
Other Expenses n/a 1.17M -171.00K 322.00K 82.00K n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses 41.76M 36.53M 50.47M 42.80M 23.21M 62.46M 53.69M 56.91M 73.74M 35.53M 13.77M 13.78M 13.15M
Interest Expense n/a n/a n/a n/a n/a n/a 971.00K 347.00K 806.00K -870.00K n/a 97.00K n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a 12.93M -212.00K -1.15M -70.00K n/a n/a n/a n/a
Cost & Expenses 41.76M 36.53M 50.47M 42.80M 23.21M 62.72M 53.88M 57.12M 73.81M 35.53M 13.78M 13.79M 13.15M
Income Tax n/a -1.17M -326.00K -155.00K -93.86K -1.60M -900.00K -300.00K -946.00K n/a n/a n/a n/a
Shares Outstanding (Basic) 43.90M 25.76M 17.16M 11.88M 9.21M 2.69M 2.29M 2.27M 2.23M 2.42M 2.18M 2.18M 2.18M
Shares Outstanding (Diluted) 43.90M 25.76M 17.16M 11.88M 9.21M 2.69M 2.29M 2.27M 2.23M 2.42M 2.18M 2.18M 2.18M
EPS (Basic) -0.84 -1.33 -2.93 -3.56 -2.51 -22.85 -22.76 -25.44 -33.32 -15.14 -6.54 -6.4 -6.07
EPS (Diluted) -0.84 -1.33 -2.93 -3.56 -2.51 -22.85 -22.76 -25.44 -33.32 -15.14 -6.54 -6.4 -6.07
EBITDA -41.45M -35.08M -50.14M -42.65M -23.14M -60.81M -52.58M -57.44M -73.41M -35.53M -14.02M -13.77M -13.15M
Depreciation & Amortization 311.00K 272.00K 326.00K 155.00K 78.00K 261.00K 188.00K 212.00K 70.00K n/a 12.00K 11.00K 4.00K